Genpact Limited (G) Balance Sheet

The reduction in debt and increase in equity over the period suggest a deliberate deleveraging trend, which may enhance financial flexibility. However, the recent uptick in debt from $1.4B in 2025Q3 to $1.8B in 2026Q1, followed by a decline to $1.4B in 2026Q2, indicates some volatility, possibly tied to working capital needs or acquisitions. Overall, the balance sheet appears to be strengthening, supporting the company's ability to invest in AI initiatives.

The D/E ratio of 0.54 is conservative relative to peers like EXLS (0.44) but higher than EPAM (0.04) and CTSH (0.10), indicating a moderate leverage position. The absolute debt level of $1.4B appears manageable given cash of $517M and strong operating cash flows, though the company's reliance on debt for acquisitions or buybacks warrants monitoring. The low leverage suggests that debt is not a necessity but rather a strategic tool, providing flexibility for capital allocation.

The minimal PPE relative to total assets confirms a service-oriented, asset-light business model. However, the substantial goodwill raises impairment risk, especially if the AI pivot underperforms or if acquired businesses fail to meet growth expectations. The decline in PPE from $414M in 2025Q2 to $184M in 2026Q2 may indicate reduced capital expenditure or asset disposals, which could affect long-term operational capacity, though this is not necessarily a negative for a services firm.

The steady increase in retained earnings, despite ongoing share repurchases and dividends, suggests that Genpact is generating sufficient profits to fund growth and shareholder returns. The equity base of $2.6B provides a solid cushion against potential write-downs or economic shocks. However, the prior cash flow analysis noted that capital returns exceeded FCF in Q2 2026, implying reliance on cash reserves or debt, which could pressure equity if sustained.

The current ratio of 2.00 indicates adequate short-term liquidity, though it has fluctuated between 1.51 and 2.45 over the past ten quarters. The decline in cash from $853M to $517M over two quarters may reflect seasonal working capital needs or capital deployment, but it still provides a buffer against operational shocks. Given the company's stable cash flows, the liquidity position appears sufficient, though investors should monitor the cash trajectory.

The decline in deferred revenue over the past two quarters may indicate softer demand or a shift in contract terms, though it remains above year-ago levels. This metric provides some forward visibility into revenue recognition, but the company's multi-year contracts and high recurring revenue base mitigate the impact. The recent earnings beat and raised guidance, as noted in the intelligence, suggest that the decline may be timing-related rather than a fundamental deterioration.